Skip to main navigation Skip to search Skip to main content

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials

  • Sally Hopewell*
  • , An-Wen Chan
  • , Gary S. Collins
  • , Asbjorn Hróbjartsson
  • , David Moher
  • , Kenneth F. Schulz
  • , Ruth Tunn
  • , Rakesh Aggarwal
  • , Michael Berkwits
  • , Jesse A. Berlin
  • , Nita Bhandari
  • , Nancy J. Butcher
  • , Marion K. Campbell
  • , Runcie C. W. Chidebe
  • , Diana Elbourne
  • , Andrew Farmer
  • , Dean A. Fergusson
  • , Robert M. Golub
  • , Steven N. Goodman
  • , Tammy C. Hoffmann
  • John P. A. Ioannidis, Brennan C. Kahan, Rachel L. Knowles, Sarah E. Lamb, Steff Lewis, Elizabeth Loder, Martin Offringa, Philippe Ravaud, Dawn P. Richards, Frank W. Rockhold, David L. Schriger, Nandi L. Siegfried, Sophie Staniszewska, Rod S. Taylor, Lehana Thabane, David Torgerson, Sunita Vohra, Ian R. White, Isabelle Boutron
*Corresponding author for this work
  • University of Oxford
  • University of Toronto
  • University of Southern Denmark
  • University of Ottawa
  • University of North Carolina at Chapel Hill
  • Jawaharlal Institute of Postgraduate Medical Education and Research
  • Centers for Disease Control and Prevention
  • Center for Pharmacoepidemiology and Treatment Science
  • American Medical Association
  • Society for Applied Studies Kolkata
  • University of Aberdeen
  • Project PINK BLUE - Health & Psychological Trust Centre
  • Miami University
  • London School of Hygiene and Tropical Medicine
  • Northwestern University
  • Stanford University
  • Bond University
  • University College London
  • University of Exeter
  • University of Edinburgh
  • BMJ
  • Harvard University
  • Centre de Recherche Epidémiologiques et Bio Statistiques de Sorbonne Paris Cité (CRESS)
  • MaRS Centre
  • Duke University
  • University of California at Los Angeles
  • South African Medical Research Council
  • University of Warwick
  • University of Glasgow
  • McMaster University
  • St. Joseph's Healthcare Hamilton
  • University of York
  • University of Alberta
  • Université Paris 13
  • Hôpital Hotel-Dieu AP-HP

Research output: Contribution to journalArticleAcademicpeer-review

73 Downloads (Pure)

Abstract

Critical appraisal of the quality of randomised trials is possible only if their design, conduct, analysis, and results are completely and accurately reported. Without transparent reporting of the methods and results, readers will not be able to fully evaluate the reliability and validity of trial findings. The CONSORT (Consolidated Standards of Reporting Trials) statement aims to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomised trial. CONSORT was first published in 1996 and was updated in 2001 and 2010. CONSORT comprises a checklist of essential items that should be included in reports of randomised trials and a diagram for documenting the flow of participants through a trial. The CONSORT statement has been updated (CONSORT 2025) to reflect recent methodological advancements and feedback from end users, ensuring that it remains fit for purpose. Here, wepresent the updated CONSORT explanation and elaboration document, which has been extensively revised and describes the rationale and scientific background for each CONSORT 2025 checklist item and provides published examples of good reporting. The objective is to enhance the use, understanding, and dissemination of CONSORT 2025 and provide guidance to authors about how to improve the reporting of their trials and ensure trial reports are complete, and transparent.

Original languageEnglish
Article numbere081124
JournalBMJ
Volume389
Early online date2025
DOIs
Publication statusPublished - 14 Apr 2025
Externally publishedYes

Fingerprint

Dive into the research topics of 'CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials'. Together they form a unique fingerprint.

Cite this